The University of Kansas Medical Center is conducting a clinical trial of male contraceptive gel that men apply to their shoulders. They are currently in search of couples to participate in the study. The study is led by investigator Dr. Ajay Nangia, vice chair of urology.
What is the Gel?
A mixture of Nestorone and testosterone, Nestorone is a synthetic progestin that blocks the production of male hormones need to generate sperm. Apparently, the testosterone element in the gel will replace testosterone typically produced in the male body. The sponsor, a nonprofit organization called The Population Council” and National institute of Health are partnering to create the gel. Other collaborative investigatory sites include the University of California, Los Angeles and the University of Washington. The University of Kansas is a sub-site, reports KCTV 5 News.
Challenge to find Participants
By January 17, the center had enrolled three people for the investigational treatment. They acknowledge that it is difficult to find participants. This is a common challenge in most clinical studies—that is, finding willing and able participants that fit in the protocol’s inclusion and exclusion criteria.
Who is the Population Council?
Founded in 1952 in New York, NY by John D. Rockefeller, the Population Council is an international, nonprofit, non-governmental organization. They conduct research in biomedicine, social science and public health and help build research capacities in developing countries. One-third of their research relates to HIV and AIDS—its other major program is reproductive health. They have an annual budget of about $74 million.
Dr. Ajay Nangia, vice chair of urology, University of Kansas (sub-site)Source: KCTV5 News